Pharmacist-Led Audit and Feedback Doubles Timely IV-to-Oral Switch in Oncology Inpatients
This single-center cohort study quantifies how pharmacist-led antimicrobial stewardship rounds change intravenous to oral switch timing, antimicrobial exposure, and nursing workload in a cancer hospital.
📅 Journal publication: 2026(online Oct 5, 2026)·Last updated: Nov 17, 2026
antimicrobial stewardshipprospective audit and feedbackintravenous to oral switchoncologypiperacillin-tazobactamceftriaxoneamoxicillin-clavulanateretrospective cohortnursing timeclinical pharmacy practiceClinical Pharmacy Practice
Background Information
Antimicrobial stewardship boosts efficient antibiotic use in oncology wards.
Antimicrobial stewardship (AMS) interventions can optimize antimicrobial use, reducing unnecessary nursing time and hospital resources in oncology settings. AMS prospective audit and feedback increased IV to oral switch rates from 40.8% to 72.5% and decreased antimicrobial use and nursing administration time. This study shows that AMS can safely improve antimicrobial management, though its single-center design may limit generalizability. Prospective audit and feedback significantly improve IV to oral antimicrobial switch rates in oncology patients.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.